 |
|
New role for tamoxifen as fertility drug for breast cancer patients?
January 03, 2003US fertility experts have discovered a potential new role for the wonder drug tamoxifen - helping breast cancer patients to have babies by IVF.
In a study published today (Wednesday 8 January) in Europe's leading reproductive medicine journal Human Reproduction [1], researchers from New York's Cornell University report the first IVF pregnancy to result from the use of tamoxifen as an ovarian stimulant.
In a study of 12 breast cancer survivors they found that stimulating the ovaries with a short, carefully timed course of tamoxifen boosted the number of eggs they could retrieve. Every patient had one or more embryos either for freezing for later attempts at pregnancy, or for immediate transfer. One patient who had two fresh embryos transferred has already given birth to twins. Another patient conceived on her second attempt although she miscarried. None of the patients with frozen embryos has yet attempted pregnancy.
Lead researcher Professor Kutluk Oktay said that the experiment arose from a desire to find a safe way of preserving fertility among the 15% of breast cancer patients - around 27,000 annually in the USA - who were still of reproductive age when they were diagnosed.
Chemotherapy causes ovarian failure in many patients - nearly as many as four out of five women in the case of those given cyclophosphamide. Even those who remain fertile or don't have chemotherapy face the problem of needing a recurrence-free period of perhaps two to five years before trying to conceive, bringing them up against the barrier of infertility due to ageing and diminishing ovarian reserves.
"These women can try natural cycle IVF without ovarian stimulation, but typically, no more than a single embryo can be achieved for immediate use or freezing. So, we need to find a safe way of increasing the number of embryos to give these women a better chance of having a baby," said Professor Oktay, assistant professor of Reproductive Medicine and Obstetrics and Gynaecology at the Center for Reproductive Medicine and Infertility, Weill Medical College of Cornell University.
Tamoxifen was developed in the UK in 1966 as a contraceptive, but found to stimulate ovarian follicle growth and became used in Europe as an ovarian stimulant. (A related compound, Clomiphene, is usually used in the USA). It wasn't until 1976 that tamoxifen's suppressive, anti-estrogenic effect on breast cancer was discovered. Since then it has become the world's most successful anti-cancer drug, saving the lives of thousands of breast cancer patients every year worldwide.
"Sometimes the best ideas are the obvious ones and tamoxifen seemed the obvious choice of drug to test, although, to my knowledge, no one has tried it before in breast cancer patients," said Professor Oktay. "We hypothesised that tamoxifen stimulation would result in higher numbers of embryos compared with natural cycle IVF, while theoretically shielding breast cancer cells against oestrogen."
A retrospective group of five breast cancer patients who had undergone nine cycles of natural cycle IVF was used as a control for the 12 study patients. The 12 patients were given 40-60 mg tamoxifen for around seven days on days 2-3 of their menstrual cycle (a total of 15 treated cycles). The tamoxifen patients produced a greater number of mature eggs than the controls (1.6 versus 0.7) and embryos (1.6 versus 0.6). All tamoxifen patients generated embryos compared with three out of five controls. After a mean follow up of around 15 months none of the study patients has had a recurrence of cancer.
"This is a novel use of tamoxifen to attempt to preserve fertility and treat chemotherapy-related infertility via IVF embryo cryopreservation and embryo transfer after breast cancer," said Professor Oktay. "We exploited tamoxifen's dual action as an ovarian stimulating drug and an anti-cancer agent."
Because most patients in the tamoxifen group froze their embryos while most in the control group had fresh embryo transfer it has not been possible yet to compare pregnancy rates between the two protocols or to provide long-term data on the effects of tamoxifen on pregnancy. However, long-term experience of the drug in ovulation induction did not suggest an embryo-damaging effect. In any case its use was discontinued prior to ovulation and egg retrieval and IVF embryos were never exposed to it as fertilisation took place in vitro.
Professor Oktay said the study had limitations with its short follow-up and its retrospective, small control group, but a larger study was planned with modifications to the protocol to include low amounts of follicle stimulating hormone (FSH) in addition to tamoxifen.
"I am optimistic," he said. "Many of my patients tell me that just doing something to address the issue of loss of reproductive function makes it easier for them to deal with breast cancer. It connects them to their future and underlines that because they have breast cancer it does not mean they have a terminal illness.
"It would be especially fitting if a drug that has saved so many women's lives should also turn out to be a means of preserving their fertility," he added.
He urged all breast cancer physicians to be aware of the effect of chemotherapy on women of reproductive age and to refer them to an appropriate assisted reproduction centre as soon as a diagnosis was made so that options for preserving fertility could be discussed.
[1] Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Human Reproduction. Vol. 18. No 1. pp 90-95.
MW Communications
Breast Cancer Current Events and Breast Cancer News RSSNursing study concludes few Ontario women with invasive ovarian cancer referred for genetic testing of breast cancer genes
An Ontario study of 491 women with invasive ovarian cancer found only a small proportion, 19%, were referred for genetic testing of BRCA1 and BRCA2, the breast cancer genes, which means family members are not informed of their cancer risk.
Angled gantry technique reduced breast radiation exposure by 50 percent
A novel angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by more than 50%, according to Thomas Jefferson University researchers.
HER2 levels may aid in treatment selection for metastatic breast cancer
Findings published in the December 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit.
Drop in cancer deaths tied primarily to gains in behavior and screening
Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University.
New breast imaging technology targets hard-to-detect cancers
Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
Delays in Radiation Therapy Lead to Increased Breast Cancer Recurrence
A new analysis of the National Cancer Institute's cancer registry has found that as many as one in five older women experience delayed or incomplete radiation treatment following breast-conserving surgery, and that this suboptimal care can lead to worse outcomes.
New mammography technology effective in detecting breast cancer
A study has found that positron emission mammography (PEM), a new technique for imaging the breast, is not affected by either breast density or a woman's hormonal status, two factors that limit the effectiveness of standard mammography and MRI at detecting cancer.
New statistical model could help reduce breast-lesion biopsies
A new method of characterizing breast lesions found during an MRI exam could result in fewer biopsies of benign tumors with the benefits of reduced pain and expense for patients and providers, according to a paper that will be presented today (Sunday, Nov. 30) at the annual meeting of the Radiological Society of North America (RSNA).
Breast cancer treatment offers better outcome to women with implants
Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
Study identifies double-balloon enteroscopy as cost-effective approach for obscure GI bleeding
A cost-effectiveness analysis conducted by researchers at Stanford University Hospital in Calif., shows that an initial double-balloon enteroscopy (DBE) is a cost-effective approach for patients with obscure gastrointestinal (GI) bleeding.
More Breast Cancer Current Events and Breast Cancer News Articles
 | Breast Cancer Husband : How to Help Your Wife (and Yourself) during Diagnosis, Treatment and Beyond by Marc Silver A unique guide, like none other on the market-packed with medical information, practical tips, psychological insight, and coping strategies-to help men help the women they love through this trying time. When Marc Silver became a breast cancer husband three years ago, he learned firsthand how frightened and helpless the breast cancer husband feels. He searched in vain for a book that would give... |
 | Breast Cancer Survival Manual, Fourth Edition: A Step-by-Step Guide for the Woman With Newly Diagnosed Breast Cancer by John Link A completely updated edition of the definitive guide for patients with breast cancer The new fourth edition of The Breast Cancer Survival Manual provides essential updates on treatment and care, enhancing the basic information that has made this the most trusted guide for women diagnosed with breast cancer for the past decade. This edition includes the most current advice on • getting a second... |
 | The Breast Cancer Survivor's Fitness Plan (Harvard Medical School Guides) by Carolyn M. Kaelin, Francesca Coltrera, Josie Gardiner, Joy Prouty The only breast cancer recovery program designed by a Harvard doctor and survivor and approved by the American Council on Exercise (ACE). . Feel healthy again. Regain control of your life. . . Exciting new research reveals that regular exercise can reduce the chance of breast cancer recurrence and extend your life. Exercise can also help you recover energy, strength, and flexibility... |
 | Chicken Soup for the Breast Cancer Survivor's Soul: Stories to Inspire, Support and Heal (Chicken Soup for the Soul) by Jack Canfield, Mark Victor Hansen, Mary Olsen Kelly Your support group in a book, filled with boundless strength and profound hope - until the fight is won. Along with the shock, fear and loss many women face upon a breast cancer diagnosis comes unexpected strength, wisdom, and strong networks of sharing, support and healing. In Chicken Soup for the Breast Cancer Survivor's Soul, survivors and their family members talk openly about how difficult... |
 | Choices in Breast Cancer Treatment: Medical Specialists and Cancer Survivors Tell You What You Need to Know (A Johns Hopkins Press Health Book) A diagnosis of breast cancer can be overwhelming. The disease is frightening and the medical landscape confusing. In the wake of fear and confusion comes the need to make decisions about treatment. This book provides women with medically reliable and up-to-date information to help them with these decisions.Within these pages is a team of private consultants -- including surgeons, medical... |
 | I Am Not My Breast Cancer: Women Talk Openly About Love and Sex, Hair Loss and Weight Gain, Mothers and Daughters, and Being a Woman with Breast Cancer by Ruth Peltason I Am Not My Breast Cancer gathers the warm, loving, frank, and informed voices of more than eight hundred women—from every state in the nation and from continents as far away as Australia and Africa—who reveal their fears, trade advice, share experiences, and express their deepest, most intimate concerns. Essential reading for any woman with this diagnosis, it offers the companionship of... |
 | The Breast Cancer Prevention Diet: The Powerful Foods, Supplements, and Drugs That Can Save Your Life by Dr. Bob Arnot "From one of the most visible and highly respected figures in medical journalism comes a book that can literally save lives. During the past several years, doctors at leading institutions across the nation have been investigating the relationship between breast cancer and diet. The recent flood of medical studies confirm that what a woman eats can have a dramatic impact on whether or not... |
 | Breast Cancer: Real Questions, Real Answers by David Chan Breast Cancer: Real Questions, Real Answers is an outgrowth of Dr. David Chan's more than 20 years in private oncology practice. Inspired by his patients—who courageously face their illness but often feel fearful, confused about their options, and full of questions—Dr. Chan's book is uniquely structured as a Question and Answer between patient and doctor. It provides readers with an easily... |
 | Breast Cancer? Breast Health! The Wise Woman Way (Wise Woman Herbal Series, Book 4) (Wise Woman Herbal Series) by Susun S. Weed Foods, exercises, and attitudes to keep your breasts healthy. Supportive complimentary medicines to ease side-effects of surgery, radiation, chemotherapy, or tamoxifen. Foreword by Christiane Northrup,... |
 | What Your Doctor May Not Tell You About(TM): Breast Cancer: How Hormone Balance Can Help Save Your Life (What Your Doctor May Not Tell You About...) by John R. Lee, David Zava, Virginia Hopkins An informative and absorbing read for both medical practitioners and their patients, What Your Doctor May Not Tell You About Breast Cancer takes aim at "the breast cancer industry" with a barrage of thought-provoking ammunition. The book is equal parts criticism and suggestion. Current health treatments, including HRT, receive serious condemnation, and authors John Lee and David Zava carefully... |
| © 2008 BrightSurf.com |